Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.1 USD | +1.14% | +0.49% | +19.41% |
04:04pm | Merck to present new oncology data | CF |
14/05 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.41% | 33TCr | |
+31.26% | 59TCr | |
-3.39% | 36TCr | |
+5.08% | 29TCr | |
+15.51% | 24TCr | |
+10.04% | 21TCr | |
-7.08% | 20TCr | |
+9.24% | 17TCr | |
-0.47% | 16TCr | |
+1.26% | 12TCr |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Barclays Raises Merck's Price Target to $135 From $130, Maintains Overweight Rating